FI97226B - Förfarande för framställning av terapeutiskt användbara 6-amino-substituerade oktahydro-1,7,8-indolizintriolderivat - Google Patents
Förfarande för framställning av terapeutiskt användbara 6-amino-substituerade oktahydro-1,7,8-indolizintriolderivat Download PDFInfo
- Publication number
- FI97226B FI97226B FI925260A FI925260A FI97226B FI 97226 B FI97226 B FI 97226B FI 925260 A FI925260 A FI 925260A FI 925260 A FI925260 A FI 925260A FI 97226 B FI97226 B FI 97226B
- Authority
- FI
- Finland
- Prior art keywords
- give
- octahydro
- indolizine
- formula
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Claims (2)
1. Förfarande för framställning av terapeutlskt användbara 6-amino-substituerade oktahydro-1,7,8-indoli- 5 zlntrlolderlvat med formeIn R"0 V/\ . NHR OR ’ väri R är C^-alkanoyl; och R', R" och R” ’ oberoende av 15 varandra betecknar väte, C^Q-alkanoyl eller bensoyl, kännetecknat av, att 6-amino-oktahydroindo-lizin med formeln HO 20 \-N HO / \ \ / (II) OH nh2 25 « bringas att reagera med en syraanhydrid med formeln R20, väri R är ovan definierad, i närvaro av vatten, varvid en amid med formeln I erhälls, vilken därefter, om sä önskas, bringas att reagera med samma syraanhydrid under vatten-30 fria förhällanden, varvid estrar med formeln I erhälls.
2. Förfarande enligt patentkrav 1, kännetecknat av, att [lS-(la,68,7a,86,8aB)-6-acetamido-oktahydro-1,7,8-indolizintriol framställs. il . liri Mb l i * tt :
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53252290 | 1990-06-04 | ||
US07/532,522 US5079254A (en) | 1990-06-04 | 1990-06-04 | Derivatives of 6-aminooctahydroindolizinetriol |
US9103179 | 1991-05-08 | ||
PCT/US1991/003179 WO1991018598A1 (en) | 1990-06-04 | 1991-05-08 | Derivatives of 6-aminooctahydroindolizinetriol |
Publications (4)
Publication Number | Publication Date |
---|---|
FI925260A0 FI925260A0 (sv) | 1992-11-19 |
FI925260A FI925260A (sv) | 1992-11-19 |
FI97226B true FI97226B (sv) | 1996-07-31 |
FI97226C FI97226C (sv) | 1996-11-11 |
Family
ID=24122149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI925260A FI97226C (sv) | 1990-06-04 | 1992-11-19 | Förfarande för framställning av terapeutiskt användbara 6-amino-substituerade oktahydro-1,7,8-indolizintriolderivat |
Country Status (15)
Country | Link |
---|---|
US (1) | US5079254A (sv) |
EP (1) | EP0532530B1 (sv) |
JP (1) | JP3019265B2 (sv) |
KR (1) | KR100195421B1 (sv) |
AT (1) | ATE155685T1 (sv) |
AU (1) | AU641771B2 (sv) |
CA (1) | CA2082820C (sv) |
DE (1) | DE69126978T2 (sv) |
DK (1) | DK0532530T3 (sv) |
ES (1) | ES2106080T3 (sv) |
FI (1) | FI97226C (sv) |
GR (1) | GR3025044T3 (sv) |
HU (1) | HU212579B (sv) |
NO (1) | NO300686B1 (sv) |
WO (1) | WO1991018598A1 (sv) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995013538A1 (en) * | 1993-11-12 | 1995-05-18 | Operon Technologies, Inc. | Methods of producing and screening complex chemical libraries |
AU1562895A (en) * | 1994-01-12 | 1995-08-01 | Massachusetts Institute Of Technology | Process for making xanthene or cubane based compounds, and protease inhibitors |
CA2526173A1 (en) * | 2003-05-22 | 2004-12-02 | The Hospital For Sick Children | Treatment of tay sachs or sandhoff diseases by enhancing hexosaminidase activity |
CA2553866A1 (en) * | 2004-01-20 | 2005-08-11 | Optimer Pharmaceuticals, Inc. | Treatment of degenerative cartilage conditions in a mammal with glycosi dase inhibitors |
KR100858512B1 (ko) | 2007-03-29 | 2008-09-12 | 포항공과대학교 산학협력단 | 헥소스아미니데이즈 활성 저해 방법 |
JP2011529857A (ja) * | 2008-08-01 | 2011-12-15 | サイモン フレイザー ユニバーシティ | 選択的グリコシダーゼインヒビターおよびその使用 |
MY165728A (en) | 2010-12-23 | 2018-04-20 | Merck Sharp & Dohme | Selective glycosidase inhibitors and uses thereof |
WO2012129651A1 (en) | 2011-03-31 | 2012-10-04 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
EP2726492B1 (en) | 2011-06-27 | 2017-11-01 | Alectos Therapeutics Inc. | Selective glycosidase inhibitors and uses thereof |
EP2890675A4 (en) | 2012-08-31 | 2016-01-13 | Alectos Therapeutics Inc | GLYCOSIDASE INHIBITORS AND USES THEREOF |
WO2014032185A1 (en) | 2012-08-31 | 2014-03-06 | Alectos Therapeutics Inc. | Glycosidase inhibitors and uses thereof |
BR112015009638A2 (pt) | 2012-10-31 | 2017-07-04 | Alectos Therapeutics Inc | inibidores de glicosidase e usos dos mesmos |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5973519A (ja) * | 1982-09-17 | 1984-04-25 | Fujisawa Pharmaceut Co Ltd | スワインソニンの製造法およびそれを含む免疫調整剤 |
GB8429810D0 (en) * | 1984-11-26 | 1985-01-03 | Fujisawa Pharmaceutical Co | Indolizidine derivatives |
JPS61277685A (ja) * | 1985-05-31 | 1986-12-08 | Fujisawa Pharmaceut Co Ltd | 新規インドリジジン誘導体、その製造法およびそれを含有する組成物 |
DE3620645A1 (de) * | 1985-12-20 | 1987-07-02 | Bayer Ag | 3-amino-4,5-dihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung |
CA1315276C (en) * | 1987-07-02 | 1993-03-30 | Paul S. Liu | Castanospermine esters and glycosides |
JPH01129182A (ja) * | 1987-11-16 | 1989-05-22 | Tokyo Keiki Co Ltd | 波動伝搬時間測定装置 |
JPH01277685A (ja) * | 1988-04-28 | 1989-11-08 | Hitachi Ltd | ピストンポンプ |
-
1990
- 1990-06-04 US US07/532,522 patent/US5079254A/en not_active Expired - Lifetime
-
1991
- 1991-05-08 HU HU9203829A patent/HU212579B/hu not_active IP Right Cessation
- 1991-05-08 WO PCT/US1991/003179 patent/WO1991018598A1/en active IP Right Grant
- 1991-05-08 EP EP91909495A patent/EP0532530B1/en not_active Expired - Lifetime
- 1991-05-08 ES ES91909495T patent/ES2106080T3/es not_active Expired - Lifetime
- 1991-05-08 CA CA002082820A patent/CA2082820C/en not_active Expired - Lifetime
- 1991-05-08 DE DE69126978T patent/DE69126978T2/de not_active Expired - Lifetime
- 1991-05-08 JP JP3509415A patent/JP3019265B2/ja not_active Expired - Lifetime
- 1991-05-08 AT AT91909495T patent/ATE155685T1/de not_active IP Right Cessation
- 1991-05-08 KR KR1019920703085A patent/KR100195421B1/ko not_active IP Right Cessation
- 1991-05-08 AU AU78743/91A patent/AU641771B2/en not_active Ceased
- 1991-05-08 DK DK91909495.3T patent/DK0532530T3/da active
-
1992
- 1992-11-19 FI FI925260A patent/FI97226C/sv not_active IP Right Cessation
- 1992-12-03 NO NO924670A patent/NO300686B1/no not_active IP Right Cessation
-
1997
- 1997-10-15 GR GR970402690T patent/GR3025044T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH05507474A (ja) | 1993-10-28 |
ATE155685T1 (de) | 1997-08-15 |
WO1991018598A1 (en) | 1991-12-12 |
KR930700502A (ko) | 1993-03-15 |
FI97226C (sv) | 1996-11-11 |
GR3025044T3 (en) | 1998-01-30 |
EP0532530A1 (en) | 1993-03-24 |
HU9203829D0 (en) | 1993-03-29 |
JP3019265B2 (ja) | 2000-03-13 |
CA2082820A1 (en) | 1991-12-05 |
FI925260A0 (sv) | 1992-11-19 |
ES2106080T3 (es) | 1997-11-01 |
EP0532530A4 (en) | 1993-05-26 |
AU641771B2 (en) | 1993-09-30 |
AU7874391A (en) | 1991-12-31 |
DK0532530T3 (da) | 1997-08-25 |
CA2082820C (en) | 2002-01-22 |
HUT62585A (en) | 1993-05-28 |
HU212579B (en) | 1996-08-29 |
EP0532530B1 (en) | 1997-07-23 |
DE69126978T2 (de) | 1997-11-27 |
NO924670L (no) | 1992-12-03 |
KR100195421B1 (ko) | 1999-06-15 |
NO300686B1 (no) | 1997-07-07 |
FI925260A (sv) | 1992-11-19 |
US5079254A (en) | 1992-01-07 |
DE69126978D1 (de) | 1997-08-28 |
NO924670D0 (no) | 1992-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI97226B (sv) | Förfarande för framställning av terapeutiskt användbara 6-amino-substituerade oktahydro-1,7,8-indolizintriolderivat | |
FI106028B (sv) | Förfarande för framställning av terapeutiskt användbara bicykliska geldanamysinderivat | |
KR20150000901A (ko) | 히스톤 탈아세틸효소(hdacs) 억제제 | |
KR20130120517A (ko) | 암을 치료하기 위한 hdac 억제제로서 4-아미노-n-하이드록시-벤즈아미드 | |
EA012295B1 (ru) | Конденсированные пирролокарбазолы | |
Ferlin et al. | Pyrrolo-quinoline derivatives as potential antineoplastic drugs | |
EP3612180B1 (en) | Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel tmem16a | |
Hu et al. | Antitumor agents. 123. Synthesis and human DNA topoisomerase II inhibitory activity of 2'-chloro derivatives of etoposide and 4. beta.-(arylamino)-4'-O-demethylpodophyllotoxins | |
TW201011034A (en) | New (poly) aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents | |
US5332811A (en) | Etopside analogs | |
US6362218B1 (en) | Brefeldin A derivatives | |
Zhou et al. | Semisynthesis and antitumor activities of new styryl-lactone derivatives | |
DE69202173T2 (de) | Phenylethanolamino- und Phenylethanolaminomethyltetraline, Verfahren zu deren Herstellung Zwischenprodukte davon und diese enthaltende pharmazeutische Zusammensetzungen. | |
DE69019217T2 (de) | Perylenquinon (UCN-1028D)-Derivate. | |
CN113527195B (zh) | 一类5-芳基烟酰胺类lsd1/hdac双靶点抑制剂、其制备方法及应用 | |
US5696119A (en) | (2-quinoxalinyloxy) phenoxypropanoic acids and related derivatives as anticancer agents | |
OHTSUKA et al. | Hispidospermidin, a novel phospholipase C inhibitor produced by Chaetosphaeronema hispidulum (Cda) Moesz NR 7127 II. Isolation, characterization and structural elucidation | |
CN111393500B (zh) | 具有共轭二烯结构c环的齐墩果酸衍生物及其制备方法和应用 | |
Donati et al. | Conformationally constrained tryptophan analogs. Synthesis of (±)-(Z)-and (±)-(E)-2-amino-2, 3-methano-3-(indol-3-yl)-propanoic acids | |
US4895854A (en) | Antitumor alkaloids | |
DE69624236T2 (de) | Ausgewählte lösliche ester von indolcarbazolen die hydroxyl enthalten | |
KR20000057268A (ko) | 나프티리딘 유도체 | |
CN115353522B (zh) | 淫羊藿素-去甲斑蝥素缀合物的区域选择性合成及抗肿瘤应用 | |
CN114195676B (zh) | 双芳基肼类化合物及其加合物和在制备抗肿瘤药物中的应用 | |
FI85140B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara n-(1h-indol-4-yl)-bensamidderivat. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
MA | Patent expired |